VELOO
VELOO is a company that operates in the apps, automotive, and sports industries. It offers a range of products and services that cater to these sectors. VELOO's offerings are diverse and cater to a wide audience, from sports enthusiasts to automotive professionals. The company's services are designed to provide solutions that meet the needs of its customers in these industries. VELOO's products and services are innovative and cater to the evolving needs of its customers. The company's offerings are designed to provide value and enhance the experience of its customers in the apps, automotive, and sports sectors.
VELOO
Social Links:
Industry:
Apps Automotive Sports
Founded:
2020-08-17
Address:
Seongnam, Kyonggi-do, South Korea
Country:
South Korea
Website Url:
http://www.veloo.net
Status:
Active
Contact:
+82 0 31 607 5349
Email Addresses:
[email protected]
Technology used in webpage:
Amazon Pound Sterling Japanese Yen Fastly Hosted Fastly Load Balancer Amazon South Korea Region
Similar Organizations
BioLudus
BioLudus is an app for entertainment and games.
CalCal
CalCal is an app for lifestyle calorie management.
Hoorah
Hoorah is an app for collecting feedback.
IckyPen
IckyPen is an app for children.
Porcupine
Porcupine is an app for live streaming and esports.
StepSetGo
StepSetGo is an app for fitness.
Investors List
Y&Archer
Y&Archer investment in Seed Round - VELOO
More informations about "VELOO"
Signs and Symptoms of hATTR Amyloidosis - Verywell Health
Feb 24, 2024 Hereditary ATTR amyloidosis occurs when a person inherits a faulty or mutated transthyretin (TTR) gene from either of their biological parents. The mutated TTR gene codes …See details»
Transthyretin Amyloidosis (ATTR-CM): Types, Causes, Treatment
May 1, 2022 Transthyretin amyloidosis (ATTR-CM) is a buildup of faulty proteins (fibrils) on your heart or nerves. It can cause cardiomyopathy and heart failure.See details»
Diagnosis and Treatment of Hereditary Transthyretin Amyloidosis (hATTR …
Hereditary transthyretin amyloidosis (hATTR) with polyneuropathy (formerly known as Familial Amyloid Polyneuropathy) is a rare disease due to mutations in the gene encoding transthyretin …See details»
hATTR: Hereditary Transthyretin Amyloidosis With Polyneuropathy - WebMD
May 15, 2025 Hereditary transthyretin amyloidosis (hATTR) with polyneuropathy is a rare disorder passed down in families that gets worse over time. It’s a result of a change in a gene, …See details»
Transthyretin Amyloid Cardiomyopathy (ATTR-CM) - American Heart Association
May 29, 2024 What is transthyretin amyloid cardiomyopathy? Transthyretin (trans-thy-re-tin) amyloid cardiomyopathy (ATTR-CM) is an underdiagnosed and potentially fatal disease of the …See details»
ATTR Amyloidosis: Symptoms, Treatment, Diagnosis, and More
Nov 13, 2024 ATTR amyloidosis results from the buildup of transthyretin in the body. It can be inherited or acquired and can affect your heart, kidneys, and nervous system. While there’s no …See details»
DISEASE OVERVIEW HEREDITARY TRANSTHYRETIN AMYLOIDOSIS
Rare, systemic disease passed down through families. Caused by genetic mutations in the transthyretin (TTR) gene, it leads to a buildup of abnormal proteins called amyloid in one. or …See details»
Familial amyloid polyneuropathy - Wikipedia
Familial amyloid polyneuropathy has an autosomal dominant pattern of inheritance. Familial amyloid polyneuropathy, also called hereditary transthyretin amyloidosis (hATTR), [1][2] or …See details»
6 Facts To Know About hATTR Amyloidosis | MyAmyloidosisTeam
Mar 21, 2025 In hATTR amyloidosis, TTR protein misfolds, creating amyloid deposits that spread throughout the body. These deposits can cause problems with the heart, nerves, or both.See details»
What Is hATTR Amyloidosis? Causes, Symptoms & Treatment
Aug 27, 2025 Hereditary transthyretin amyloidosis (hATTR amyloidosis) is a specific type of this condition, inherited through families, where the transthyretin (TTR) protein misfolds and forms …See details»
What is hattr amyloidosis? - Drugs.com
Nov 20, 2024 Hattr amyloidosis is an abbreviation for a rare condition called Hereditary transthyretin-mediated (hATTR) amyloidosis. hATTR amyloidosis gets worse with time and is …See details»
Hereditary Transthyretin Amyloidosis Guidelines - Rare Disease …
For hATTR with predominant neuropathy, the expert group recommends consultation with a multidisciplinary team, which should include neurologists, cardiologists, and ophthalmologists.See details»
What is hATTR amyloidosis? - American Heart Association
Hereditary ATTR (hATTR) amyloidosis is an inherited condition. People who have it are born with a genetic variant affecting a protein called transthyretin (TTR), which is primarily made by the …See details»
Transthyretin Amyloid Cardiomyopathy: What Is It and How Rare …
3 days ago While still considered a rare disease, transthyretin amyloid cardiomyopathy (ATTR-CM) is nevertheless emerging in more people than previously thought due to increased …See details»
7 hATTR Amyloidosis Symptoms To Watch For
Feb 18, 2025 Hereditary transthyretin (hATTR) amyloidosis is a rare, progressive disease caused by abnormal proteins that clump together and become stuck in organs throughout the …See details»
Alnylam Pharmaceuticals Press Release | Aug 31, 2025 | New Data …
6 days ago Collectively, AMVUTTRA has more than 8,000 patient-years of experience worldwide and is the first RNAi therapeutic approved for the treatment of both the cardiomyopathy …See details»
Wild-type – Amyloidosis Foundation
It is often overlooked as an amyloidosis disease because so many people experience heart problems in their later years. As with hereditary forms of the disease (hATTR) wild-type ATTR …See details»
hATTR Amyloidosis Treatment: Drugs, Transplant, CAM
Mar 8, 2024 Hereditary transthyretin amyloidosis, or hATTR, is a rare disease that causes proteins to build up in the body, forming amyloid deposits. This causes serious, wide-ranging …See details»
TREATMENT OVERVIEW HEREDITARY TRANSTHYRETIN AMYLOIDOSIS
Improve and extend the lives of those with amyloidosis. ARC is committed to collaborative eforts that accelerate the pace of discovery, expand patient access to the most e. ective care, and …See details»
Echocardiography gets to the heart of cardiac amyloidosis
1 day ago Imaging data support the clinical effects of RNA interference agent vutrisiran in patients with transthyretin amyloidosis with cardiomyopathy — and point to a potential new …See details»